These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38821164)

  • 21. Chemotherapy-driven increases in the CDKN1A/PTN/PTPRZ1 axis promote chemoresistance by activating the NF-κB pathway in breast cancer cells.
    Huang P; Ouyang DJ; Chang S; Li MY; Li L; Li QY; Zeng R; Zou QY; Su J; Zhao P; Pei L; Yi WJ
    Cell Commun Signal; 2018 Nov; 16(1):92. PubMed ID: 30497491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.
    Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R
    Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
    Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
    Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pleiotrophin suppression of receptor protein tyrosine phosphatase-β/ζ maintains the self-renewal competence of fetal human oligodendrocyte progenitor cells.
    McClain CR; Sim FJ; Goldman SA
    J Neurosci; 2012 Oct; 32(43):15066-75. PubMed ID: 23100427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activation.
    Cho SG; Yi Z; Pang X; Yi T; Wang Y; Luo J; Wu Z; Li D; Liu M
    Cancer Res; 2009 Sep; 69(17):7062-70. PubMed ID: 19671799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK.
    Grzelinski M; Steinberg F; Martens T; Czubayko F; Lamszus K; Aigner A
    Neoplasia; 2009 Feb; 11(2):145-56. PubMed ID: 19177199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pleiotrophin induces nitric oxide dependent migration of endothelial progenitor cells.
    Heiss C; Wong ML; Block VI; Lao D; Real WM; Yeghiazarians Y; Lee RJ; Springer ML
    J Cell Physiol; 2008 May; 215(2):366-73. PubMed ID: 17960557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
    Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K
    Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin affin regulatory peptide/pleiotrophin negatively affects diverse biological activities in C6 glioma cells.
    Parthymou A; Lampropoulou E; Mikelis C; Drosou G; Papadimitriou E
    Eur J Cell Biol; 2008 Jan; 87(1):17-29. PubMed ID: 17881084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TKI-31 inhibits angiogenesis by combined suppression signaling pathway of VEGFR2 and PDGFRbeta.
    Zhong L; Guo XN; Zhang XH; Sun QM; Tong LJ; Wu ZX; Luo XM; Jiang HL; Nan FJ; Zhang XW; Lin LP; Ding J
    Cancer Biol Ther; 2006 Mar; 5(3):323-30. PubMed ID: 16575201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LRRC4 inhibits glioblastoma cell proliferation, migration, and angiogenesis by downregulating pleiotropic cytokine expression and responses.
    Wu M; Huang C; Li X; Li X; Gan K; Chen Q; Tang Y; Tang K; Shen S; Li G
    J Cell Physiol; 2008 Jan; 214(1):65-74. PubMed ID: 17541939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The extract of Polygoni Cuspidati Rhizoma et Radix suppresses the vascular endothelial growth factor-induced angiogenesis.
    Hu WH; Chan GK; Lou JS; Wu QY; Wang HY; Duan R; Cheng MY; Dong TT; Tsim KW
    Phytomedicine; 2018 Mar; 42():135-143. PubMed ID: 29655679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2.
    Lai L; Liu J; Zhai D; Lin Q; He L; Dong Y; Zhang J; Lu B; Chen Y; Yi Z; Liu M
    Br J Pharmacol; 2012 Feb; 165(4b):1084-96. PubMed ID: 21658027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and function of the receptor protein tyrosine phosphatase zeta and its ligand pleiotrophin in human astrocytomas.
    Ulbricht U; Brockmann MA; Aigner A; Eckerich C; Müller S; Fillbrandt R; Westphal M; Lamszus K
    J Neuropathol Exp Neurol; 2003 Dec; 62(12):1265-75. PubMed ID: 14692702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis-related endothelial cell functions and angiogenesis in vivo.
    Kunimasa K; Ikekita M; Sato M; Ohta T; Yamori Y; Ikeda M; Kuranuki S; Oikawa T
    Cancer Sci; 2010 Nov; 101(11):2462-9. PubMed ID: 20670297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of pleiotrophin in proliferative diabetic retinopathy.
    Zhu X; Bai Y; Yu W; Pan C; Jin E; Song D; Xu Q; Yao Y; Huang L; Tao Y; Li X; Zhao M
    PLoS One; 2015; 10(1):e0115523. PubMed ID: 25617851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelium-derived nitric oxide (NO) activates the NO-epidermal growth factor receptor-mediated signaling pathway in bradykinin-stimulated angiogenesis.
    Moraes MS; Costa PE; Batista WL; Paschoalin T; Curcio MF; Borges RE; Taha MO; Fonseca FV; Stern A; Monteiro HP
    Arch Biochem Biophys; 2014 Sep; 558():14-27. PubMed ID: 24960080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrastrong trapping of VEGF by graphene oxide: Anti-angiogenesis application.
    Lai PX; Chen CW; Wei SC; Lin TY; Jian HJ; Lai IP; Mao JY; Hsu PH; Lin HJ; Tzou WS; Chen SY; Harroun SG; Lai JY; Huang CC
    Biomaterials; 2016 Dec; 109():12-22. PubMed ID: 27639528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis.
    Chiodelli P; Rezzola S; Urbinati C; Federici Signori F; Monti E; Ronca R; Presta M; Rusnati M
    Oncogene; 2017 Nov; 36(47):6531-6541. PubMed ID: 28783175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pleiotrophin, a multifunctional angiogenic factor: mechanisms and pathways in normal and pathological angiogenesis.
    Perez-Pinera P; Berenson JR; Deuel TF
    Curr Opin Hematol; 2008 May; 15(3):210-4. PubMed ID: 18391787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.